Discovery Life Sciences
Discovery Life Sciences, headquartered in the United States, is a leading provider in the biospecimen and laboratory services industry. Founded in 2013, the company has rapidly established itself as a key player, offering a comprehensive range of services that include biospecimen procurement, biobanking, and advanced laboratory testing. With operational facilities across major regions in the US, Discovery Life Sciences is renowned for its commitment to quality and innovation. Their unique approach combines cutting-edge technology with a deep understanding of the life sciences sector, ensuring that clients receive unparalleled support in their research and development efforts. Notable achievements include a robust portfolio of core products and services that cater to the needs of pharmaceutical, biotechnology, and academic institutions. Discovery Life Sciences continues to solidify its market position through strategic partnerships and a dedication to advancing scientific discovery.
DitchCarbon Score
How does Discovery Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Discovery Life Sciences's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Discovery Life Sciences's reported carbon emissions
Discovery Life Sciences, headquartered in the United States, currently does not have available carbon emissions data for the most recent year. However, the company has made significant commitments towards reducing its carbon footprint. Discovery Life Sciences is committed to near-term reduction targets, although specific numerical targets have not been disclosed. The company has not yet committed to a net-zero target or defined a long-term reduction goal. As part of the pharmaceuticals, biotechnology, and life sciences sector, Discovery Life Sciences is actively engaging in initiatives to address climate change and reduce greenhouse gas emissions. The absence of specific emissions data highlights the importance of transparency and accountability in corporate climate commitments. The company’s ongoing efforts reflect a growing trend within the industry to prioritise sustainability and environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Discovery Life Sciences is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
